Panagora Asset Management’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Panagora Asset Management’s Portfolio EMMA Stock Details EMMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-709	Closed	-$8K	–	2516
2018 Q2	$8K	Buy	+709	New	+$9.37K	﹤0.01%	2290
2017 Q4	–	Sell	-1,100	Closed	-$25K	–	2394
2017 Q3	$25K	Buy	+1,100	New	+$25.6K	﹤0.01%	2157

Other funds holding EMMA

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Panagora Asset Management's EMMA Position: Q3 2018 in Review

Panagora Asset Management sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2018, closing a stake of 709 shares — an estimated $8K sold.

Panagora Asset Management first reported a position in EMMA in Q3 2017 and held it in 2 quarters. The position peaked at $25K in Q3 2017. 9 funds tracked by Wall St. Rank hold EMMA as of Q3 2018.

Panagora Asset Management reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Panagora Asset Management sold 709 Emmaus Life Sciences, Inc. Common Stock shares in Q3 2018, an estimated $8K.
Panagora Asset Management first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q3 2017 and held it in 2 quarters.
Panagora Asset Management's Emmaus Life Sciences, Inc. Common Stock position peaked at $25K in Q3 2017.
9 funds tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2018.

Based on Panagora Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.